Refining checkpoint inhibition in triple-negative breast cancer (TNBC)

Who really benefits from IO? Can we identify subsets that benefit and how to measure? (ID 18)

Lecture Time
17:05 - 17:25
Room
Hamburg Hall
Date
Thu, 11.05.2023
Time
16:45 - 18:15
Speakers
  • Justin Balko (Nashville, TN, United States of America)
Authors
  • Justin Balko (Nashville, TN, United States of America)